Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, September 2016

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 22 followers.

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand. https://t.co/MawsPM1UNv #Costeffectiveness #dipeptidylpeptidase4inhibitor #elderly #type2diabetes #Thailand

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand. https://t.co/MawsPM1UNv